Recombinant Rana esculenta Calsequestrin-1

What is Recombinant Rana esculenta Calsequestrin-1?

Recombinant Rana esculenta Calsequestrin-1 is a laboratory-produced version of the calcium-binding protein calsequestrin-1 from the edible frog (Rana esculenta, also known as Pelophylax esculentus). It typically consists of amino acids 23-420 of the native protein sequence and is often produced with affinity tags such as His-tag to facilitate purification and detection in experimental settings . The protein is primarily expressed in the sarcoplasmic reticulum of skeletal muscle, where it serves as a major calcium-binding protein crucial for muscle contraction and relaxation . When produced recombinantly, it is typically expressed in systems such as yeast to ensure proper protein folding and maintain functional properties similar to the native protein .

What expression systems are commonly used for producing Recombinant Rana esculenta Calsequestrin-1?

Recombinant Rana esculenta Calsequestrin-1 can be produced in several expression systems, each with distinct advantages for different research applications. The most common expression systems include:

• Yeast expression system: Considered one of the most economical and efficient eukaryotic systems for calsequestrin expression. This system allows for proper protein folding and post-translational modifications that may be important for protein function .

• Bacterial expression (E. coli): While not documented specifically for Rana esculenta Calsequestrin-1 in the provided search results, E. coli systems are commonly used for other calsequestrins when basic protein structure studies are the primary goal.

• Mammalian cell expression: For studies requiring proteins with modifications most similar to native conditions, mammalian expression systems like HEK293T cells can be used, though these systems are more costly and have lower yield than yeast or bacterial systems .

The choice of expression system should be determined by the specific requirements of the research question, balancing considerations of protein authenticity, yield, cost, and downstream applications.

How does the calcium binding capacity of Rana esculenta Calsequestrin-1 compare to mammalian calsequestrins?

Rana esculenta Calsequestrin-1 demonstrates significantly enhanced calcium binding properties compared to mammalian counterparts. Comparative studies have revealed that frog terminal cisternae (TC) containing Calsequestrin-1 exhibit a calcium binding capacity that is 3-4 times higher than that observed in rabbit TC . Specifically, the calcium binding capacity of frog Calsequestrin-1 was measured at either 624 or 45 nmol of Ca²⁺/mg of TC protein (depending on experimental conditions) .

This remarkable difference in calcium binding capacity is attributed to:

• Higher content of Calsequestrin-1 in frog terminal cisternae (approximately 50% higher than in rabbit)

• Potential structural differences in the protein that enhance its calcium coordination capacity

• Evolutionary adaptations that may reflect the specific physiological requirements of amphibian muscle function

These differences highlight the importance of studying amphibian Calsequestrin-1 as a model for understanding the structural determinants of high-capacity calcium storage in muscle tissue .

What are the calcium release properties of sarcoplasmic reticulum containing Rana esculenta Calsequestrin-1?

Sarcoplasmic reticulum (SR) terminal cisternae containing Rana esculenta Calsequestrin-1 exhibit distinctive calcium release kinetics compared to mammalian counterparts. Research has demonstrated that:

• After active calcium preloading in the presence of pyrophosphate, frog terminal cisternae show significantly faster calcium release rates when stimulated with caffeine and doxorubicin.

• The calcium release rate from frog terminal cisternae reaches approximately 14 μmol of Ca²⁺/min/mg of protein, which is substantially faster than the 3 μmol of Ca²⁺/min/mg of protein observed in rabbit terminal cisternae .

• This enhanced release capacity may serve an important physiological function, as it could compensate for the greater diffusion distance that calcium ions must travel from the Z-line to the actomyosin cross-bridges in the A-I overlap region in amphibian muscle fibers .

These unique calcium release properties make Recombinant Rana esculenta Calsequestrin-1 particularly valuable for studying the mechanisms of rapid calcium mobilization in muscle tissue and the evolutionary adaptations that enable efficient excitation-contraction coupling across different vertebrate species.

How do the structural features of Rana esculenta Calsequestrin-1 contribute to its function?

The structural features of Rana esculenta Calsequestrin-1 are intricately linked to its enhanced calcium binding and release properties. While the specific crystal structure of the frog protein has not been detailed in the provided references, several structural elements can be inferred from functional studies and sequence analysis:

• The protein contains numerous acidic residues, particularly in the C-terminal region, which provide multiple low-affinity calcium binding sites. This is evidenced by the extended string of aspartic acid residues (D) visible in the protein sequence .

• Electron microscopy studies of terminal cisternae vesicles containing Calsequestrin-1 reveal electron-opaque material within the vesicles, which corresponds to concentrated Calsequestrin-1, and square-like "feet" projections at the outer surface, which are likely involved in calcium channel interactions .

• The protein's tertiary structure likely facilitates the formation of higher-order assemblies within the sarcoplasmic reticulum lumen, creating a calcium-buffering network that can rapidly bind and release large amounts of calcium.

• Species-specific antigenic differences identified between frog and rabbit terminal cisternae proteins suggest structural variations that may contribute to the functional differences observed between amphibian and mammalian calsequestrins .

These structural adaptations collectively enable Rana esculenta Calsequestrin-1 to serve as a high-capacity, rapid-release calcium buffer in skeletal muscle, supporting the unique physiological demands of amphibian locomotion.

What are the optimal methods for isolating terminal cisternae containing native Rana esculenta Calsequestrin-1?

The isolation of terminal cisternae (TC) containing native Rana esculenta Calsequestrin-1 requires careful fractionation techniques to maintain structural and functional integrity. Based on established protocols, the following methodology is recommended:

• Tissue preparation: Harvest fast-twitch skeletal muscle from Rana esculenta specimens, ensuring rapid processing to minimize protein degradation.

• Homogenization: Homogenize the tissue in an appropriate buffer containing protease inhibitors to preserve protein structure.

• Differential centrifugation: Perform initial centrifugation steps to remove debris and isolate crude sarcoplasmic reticulum fractions.

• Isopycnic sucrose density gradient centrifugation: Layer the crude fraction onto a sucrose gradient (typically 38-45% interface) and centrifuge to separate terminal cisternae from other sarcoplasmic reticulum components .

• Verification of fraction purity: Confirm the identity and purity of isolated terminal cisternae through:

  • Thin section electron microscopy, looking for vesicles with electron-opaque material and square-like "feet" projections

  • Protein composition analysis (presence of Ca²⁺-ATPase, Calsequestrin-1, and high molecular weight proteins)

  • Functional Ca²⁺ flux assessments

This methodology has been successfully employed to isolate terminal cisternae fractions that retain native calcium handling properties, making them suitable for comparative studies between amphibian and mammalian sarcoplasmic reticulum function.

What are the critical considerations when expressing and purifying Recombinant Rana esculenta Calsequestrin-1?

Expressing and purifying Recombinant Rana esculenta Calsequestrin-1 requires attention to several critical factors to ensure protein functionality and experimental reproducibility:

• Expression system selection:

  • Yeast expression systems provide a good balance of proper folding and cost-effectiveness

  • The expression host should be selected based on the specific research requirements for post-translational modifications and protein conformation

• Affinity tag considerations:

  • His-tag is commonly used for purification of Recombinant Rana esculenta Calsequestrin-1

  • The tag placement (N- or C-terminal) should be carefully considered to minimize interference with protein function

• Purification strategy:

  • Affinity chromatography (e.g., using anti-tag antibodies or metal affinity for His-tagged proteins)

  • Follow with conventional chromatography steps to achieve high purity (>90%)

• Quality control assessments:

  • SDS-PAGE and Coomassie blue staining to verify purity

  • Western blotting to confirm identity

  • Functional assays to verify calcium binding capacity

• Storage conditions:

  • Store at -80°C to maintain stability

  • Avoid repeated freeze-thaw cycles which can compromise protein integrity

  • Use appropriate buffers with glycerol as a cryoprotectant

• Validation of functional properties:

  • Confirm calcium binding capacity using established assays

  • Compare functional properties to native protein where possible

Following these considerations will help ensure that the recombinant protein maintains properties similar to the native protein and is suitable for downstream experimental applications.

What techniques are most effective for measuring calcium binding and release properties of Recombinant Rana esculenta Calsequestrin-1?

Several complementary techniques can be employed to accurately measure the calcium binding and release properties of Recombinant Rana esculenta Calsequestrin-1:

• For calcium binding capacity assessment:

  • Equilibrium dialysis against known calcium concentrations

  • Isothermal titration calorimetry (ITC) to determine binding constants and thermodynamic parameters

  • 45Ca²⁺ binding assays using filtration or centrifugation to separate bound and free calcium

  • Spectroscopic methods using calcium-sensitive dyes or intrinsic fluorescence changes

• For calcium release measurements:

  • Active calcium preloading of terminal cisternae or reconstituted vesicles in the presence of pyrophosphate

  • Calcium release triggered by known agonists such as caffeine and doxorubicin

  • Continuous monitoring of calcium flux using calcium-sensitive dyes or calcium-selective electrodes

  • Stopped-flow spectrofluorometry for rapid kinetics assessment

• Comparative analysis protocols:

  • Side-by-side experiments with mammalian calsequestrins (e.g., rabbit) using identical conditions

  • Standardization of protein concentrations and experimental parameters to enable direct comparison of binding capacity (nmol Ca²⁺/mg protein)

• Structural correlations:

  • Circular dichroism spectroscopy to assess secondary structure changes upon calcium binding

  • Limited proteolysis to identify calcium-induced conformational changes

These methodologies should be selected and optimized based on the specific research question and available equipment, with careful attention to experimental conditions that might affect calcium binding properties.

What are the major functional differences between amphibian and mammalian calsequestrin-1?

Comparative studies between amphibian (Rana esculenta) and mammalian (primarily rabbit) Calsequestrin-1 have revealed several significant functional differences that highlight evolutionary adaptations in calcium handling mechanisms:

*Depending on experimental conditions

These functional differences are believed to reflect adaptations to specific physiological requirements:

• The higher calcium binding capacity and faster release rates in frog Calsequestrin-1 may compensate for the greater diffusion distance in amphibian muscle architecture, where calcium must travel further from the Z-line to the actomyosin cross-bridges in the A-I overlap region .

• These adaptations may support the rapid, high-power contractions required for frog jumping and swimming behaviors, which demand quick calcium mobilization and sequestration.

• The species-specific antigenic differences suggest structural variations that have evolved to optimize calsequestrin function in different vertebrate lineages over evolutionary time .

These comparative insights provide valuable perspective on how calcium handling proteins have adapted to meet the specific physiological demands of different vertebrate species.

How do post-translational modifications differ between recombinant and native Rana esculenta Calsequestrin-1?

Post-translational modifications (PTMs) can significantly impact protein function, and differences between recombinant and native Rana esculenta Calsequestrin-1 warrant careful consideration in experimental design. While the provided search results do not directly address this specific comparison, we can infer several important considerations based on general protein biochemistry principles and expression system properties:

• Potential PTM differences by expression system:

  • Yeast-expressed Recombinant Rana esculenta Calsequestrin-1 may exhibit glycosylation patterns that differ from native amphibian modifications, though the yeast system generally provides more accurate eukaryotic modifications than bacterial systems .

  • Phosphorylation states may vary between recombinant and native protein due to differences in kinase activities between expression hosts and native tissue.

  • C-terminal processing and other proteolytic events may differ between expression systems.

• Functional implications:

  • PTM differences might affect calcium binding affinity or capacity, potentially requiring calibration when extrapolating from recombinant to native protein function.

  • Protein-protein interaction domains could be modified differently, potentially affecting associations with other sarcoplasmic reticulum proteins.

• Analytical approaches:

  • Mass spectrometry analysis of both native and recombinant proteins would be necessary to comprehensively catalog PTM differences.

  • Functional assays comparing native terminal cisternae fractions with reconstituted systems containing recombinant protein can help quantify the impact of PTM differences.

Researchers should carefully validate recombinant protein function against native protein where possible, particularly when studying fine regulatory mechanisms that might be influenced by subtle PTM differences.

What evolutionary insights can be gained from studying Rana esculenta Calsequestrin-1 compared to other vertebrate species?

Studying Rana esculenta Calsequestrin-1 in comparison with other vertebrate species provides valuable evolutionary insights into calcium handling adaptations across the vertebrate lineage:

• Evolutionary adaptation of calcium storage mechanisms:

  • The enhanced calcium binding capacity of amphibian Calsequestrin-1 (3-4 times higher than mammalian counterparts) suggests divergent evolutionary pressures on calcium handling systems .

  • These differences likely reflect adaptations to specific environmental niches and locomotor strategies that evolved as vertebrates transitioned from aquatic to terrestrial environments.

• Structure-function relationships across vertebrate phylogeny:

  • The species-specific antigenic differences identified between frog and rabbit calsequestrins indicate structural evolution while maintaining core functionality .

  • Comparative sequence analysis across species can help identify conserved domains essential for basic function versus variable regions that may confer species-specific properties.

• Physiological correlates of molecular evolution:

  • The faster calcium release rates in frog terminal cisternae correlate with the greater diffusion distances in amphibian muscle architecture, suggesting co-evolution of molecular properties with tissue organization .

  • These adaptations potentially reflect the need for rapid, powerful muscle contractions required for escape behaviors in amphibians.

• Insights for human health applications:

  • Understanding how calcium handling evolved across species can inform therapeutic approaches for human muscle diseases involving calcium dysregulation.

  • Naturally occurring variations that enhance function (like those in amphibian Calsequestrin-1) might inspire biomimetic strategies for treating conditions with impaired calcium handling.

These evolutionary insights highlight how comparative studies of Calsequestrin-1 across species can contribute to both fundamental understanding of vertebrate physiology and potential biomedical applications.

How can Recombinant Rana esculenta Calsequestrin-1 be used in studies of excitation-contraction coupling?

Recombinant Rana esculenta Calsequestrin-1 offers unique advantages for investigating fundamental mechanisms of excitation-contraction coupling in muscle physiology:

• Comparative model system:

  • The enhanced calcium binding capacity and release kinetics of frog Calsequestrin-1 provide an excellent comparative model to understand the molecular determinants of efficient calcium handling during muscle contraction .

  • By comparing amphibian and mammalian systems, researchers can isolate critical factors that optimize excitation-contraction coupling across different muscle architectures.

• Reconstitution experiments:

  • Purified Recombinant Rana esculenta Calsequestrin-1 can be incorporated into artificial lipid bilayers or vesicle systems along with calcium release channels (ryanodine receptors) to study their functional interaction.

  • Such reconstitution systems allow precise manipulation of protein concentrations and environmental conditions to determine how Calsequestrin-1 modulates calcium release channel activity.

• Structure-function relationship studies:

  • Site-directed mutagenesis of recombinant protein can identify specific residues responsible for the enhanced calcium binding capacity and release rates observed in the amphibian protein.

  • Chimeric proteins combining domains from amphibian and mammalian calsequestrins can pinpoint regions responsible for functional differences.

• Investigation of calcium diffusion dynamics:

  • The faster calcium release properties of systems containing amphibian Calsequestrin-1 make it valuable for studying calcium wave propagation in muscle models.

  • These studies can help understand how calcium signal amplification and propagation are optimized in different muscle types.

By leveraging the unique properties of Recombinant Rana esculenta Calsequestrin-1, researchers can gain deeper insights into the molecular mechanisms that govern the speed and efficiency of muscle contraction across vertebrate species.

What experimental approaches can resolve contradictory findings in Calsequestrin-1 research?

When confronted with contradictory findings in Calsequestrin-1 research, several methodological approaches can help resolve discrepancies and advance understanding:

• Standardization of experimental conditions:

  • Develop consensus protocols for protein purification, calcium binding assays, and functional tests to enable direct comparison between studies.

  • Establish reference standards and positive controls that can be shared between laboratories to calibrate experimental systems.

• Multi-technique validation:

  • Apply complementary methodologies to measure the same parameters (e.g., calcium binding capacity measured by both equilibrium dialysis and isothermal titration calorimetry).

  • Cross-validate findings using both in vitro reconstituted systems and ex vivo native preparations to bridge between reductionist and physiological contexts.

• Consideration of species-specific differences:

  • Explicitly account for species origin in all experiments, as demonstrated by the significant functional differences between amphibian and mammalian Calsequestrin-1 .

  • Develop comparative frameworks that can distinguish universal properties from species-specific adaptations.

• Isolation of variables affecting protein function:

  • Systematically evaluate how experimental factors (pH, ionic strength, temperature, presence of other proteins) affect Calsequestrin-1 function.

  • Control for post-translational modifications by using mass spectrometry to characterize protein samples before functional testing.

• Development of computational models:

  • Create integrated mathematical models that can test whether apparently contradictory experimental results might be explained by differences in experimental conditions or interpretation.

  • Use molecular dynamics simulations to predict how structural differences might lead to functional variations.

By implementing these approaches, researchers can resolve contradictions, establish consensus findings, and develop a more nuanced understanding of Calsequestrin-1 biology across different experimental systems and species.

How might Recombinant Rana esculenta Calsequestrin-1 contribute to understanding pathological conditions affecting calcium homeostasis?

Recombinant Rana esculenta Calsequestrin-1, with its enhanced calcium handling properties, offers unique perspectives for understanding and potentially addressing pathological conditions involving calcium homeostasis:

• Comparative insights for human muscle disorders:

  • The higher calcium binding capacity of amphibian Calsequestrin-1 provides a natural model of enhanced calcium buffering that could inform therapeutic approaches for conditions characterized by calcium handling defects .

  • Structural features responsible for this enhanced capacity could inspire biomimetic designs for therapeutic interventions in conditions like malignant hyperthermia or certain muscular dystrophies.

• Investigation of calcium overload mechanisms:

  • The faster calcium release kinetics observed in frog terminal cisternae offer a model system for studying how muscles can efficiently manage rapid calcium fluxes without pathological consequences .

  • This could provide insights into conditions where calcium overload contributes to cellular damage, such as in ischemia-reperfusion injury.

• Structure-function relationship studies:

  • Comparative analysis of amphibian versus human Calsequestrin-1 can identify critical domains that might be targeted for therapeutic modification in human disease conditions.

  • Understanding how natural variations in protein structure affect function can help predict the consequences of pathogenic mutations in human Calsequestrin-1.

• Development of bioinspired calcium buffering systems:

  • The high calcium binding capacity of Rana esculenta Calsequestrin-1 could inspire the development of efficient calcium chelators for experimental or therapeutic applications.

  • Engineered proteins based on amphibian Calsequestrin-1 might serve as research tools for manipulating calcium concentrations in experimental systems.

• Evolutionary medicine perspectives:

  • Studying how different vertebrate lineages have optimized calcium handling can provide evolutionary context for human calcium-related pathologies.

  • This comparative approach may reveal alternative molecular strategies for managing calcium fluxes that could inform novel therapeutic directions.

By leveraging the unique properties of Recombinant Rana esculenta Calsequestrin-1, researchers can gain new perspectives on calcium homeostasis mechanisms that may ultimately contribute to innovative approaches for addressing human pathologies.

What emerging technologies could enhance our understanding of Rana esculenta Calsequestrin-1 structure and function?

Several cutting-edge technologies are poised to revolutionize our understanding of Rana esculenta Calsequestrin-1 structure and function in the coming years:

• Advanced structural biology approaches:

  • Cryo-electron microscopy could reveal the high-resolution structure of Calsequestrin-1 polymers within the native sarcoplasmic reticulum environment.

  • X-ray free-electron laser (XFEL) crystallography might capture dynamic structural changes during calcium binding and release.

  • Integrative structural biology combining multiple data sources (NMR, X-ray, cryo-EM, mass spectrometry) could provide comprehensive structural models across different functional states.

• Single-molecule techniques:

  • FRET-based approaches could monitor conformational changes in individual Calsequestrin-1 molecules during calcium binding and release.

  • Optical tweezers or atomic force microscopy might measure mechanical properties of Calsequestrin-1 polymers and how they change with calcium concentration.

• Advanced imaging technologies:

  • Super-resolution microscopy techniques could visualize Calsequestrin-1 organization within the terminal cisternae at nanometer resolution.

  • Correlative light and electron microscopy might connect dynamic calcium signals with ultrastructural changes in Calsequestrin-1 organization.

• Gene editing and synthetic biology:

  • CRISPR/Cas9-mediated genetic engineering of amphibian models could create chimeric or modified Calsequestrin-1 variants to test structure-function hypotheses in vivo.

  • Synthetic biology approaches might create minimal systems that recapitulate essential Calsequestrin-1 functions for more controlled mechanistic studies.

• Computational approaches:

  • Machine learning algorithms could identify subtle structural patterns that correlate with enhanced calcium binding capacity across species.

  • Molecular dynamics simulations incorporating increasing computational power could model calcium binding dynamics at unprecedented time scales and resolution.

These emerging technologies, especially when used in complementary combinations, promise to provide new insights into the molecular mechanisms underlying the remarkable calcium handling properties of Rana esculenta Calsequestrin-1.

What knowledge gaps remain in our understanding of species-specific adaptations in Calsequestrin-1?

Despite significant advances in understanding amphibian Calsequestrin-1, several important knowledge gaps remain regarding species-specific adaptations of this critical calcium-handling protein:

• Molecular basis of enhanced calcium binding:

  • While we know that frog Calsequestrin-1 has higher calcium binding capacity, the precise structural features responsible for this enhancement remain incompletely characterized .

  • The relationship between primary sequence differences and tertiary structural adaptations has not been fully elucidated.

• Evolutionary trajectory across vertebrate lineages:

  • A comprehensive phylogenetic analysis of Calsequestrin-1 across diverse vertebrate species is needed to understand when and how the enhanced calcium binding properties evolved in amphibians.

  • Whether similar adaptations evolved independently in other lineages with high-performance muscle requirements remains unknown.

• Physiological significance of species differences:

  • While it has been proposed that higher calcium binding capacity compensates for greater diffusion distances in frog muscle , direct experimental validation of this hypothesis across multiple species is lacking.

  • The relationship between Calsequestrin-1 properties and specific locomotor behaviors or ecological niches across species remains unexplored.

• Regulatory network adaptations:

  • How species-specific Calsequestrin-1 adaptations are integrated with other components of the calcium handling machinery (ryanodine receptors, SERCA pumps, etc.) is poorly understood.

  • The co-evolution of interacting proteins in the calcium regulatory network deserves systematic investigation.

• Developmental regulation and plasticity:

  • Little is known about how expression and function of amphibian Calsequestrin-1 might change during development or in response to environmental challenges.

  • The potential for adaptive plasticity in Calsequestrin-1 expression or function remains largely unexplored.

Addressing these knowledge gaps will require integrative approaches combining comparative genomics, structural biology, physiology, and evolutionary biology to develop a comprehensive understanding of how Calsequestrin-1 has adapted to meet the specific needs of different vertebrate lineages.

How might interdisciplinary approaches advance Calsequestrin-1 research beyond traditional boundaries?

Interdisciplinary approaches have the potential to dramatically expand our understanding of Calsequestrin-1 biology by connecting traditionally separate fields and methodologies:

• Integrating evolutionary biology with structural biochemistry:

  • Applying phylogenetic comparative methods to relate Calsequestrin-1 sequence evolution to structural adaptations across vertebrate lineages.

  • Using ancestral sequence reconstruction to recreate and characterize extinct forms of Calsequestrin-1, providing insights into the evolutionary trajectory of calcium handling.

• Connecting biophysics with systems biology:

  • Developing multi-scale models that link molecular properties of Calsequestrin-1 to whole-cell calcium dynamics and ultimately to muscle performance.

  • Integrating data from single-molecule studies through to tissue-level calcium imaging to understand emergent properties of the calcium handling system.

• Bridging basic science with biomedical applications:

  • Translating insights from amphibian Calsequestrin-1's enhanced calcium binding properties to design improved calcium handling in engineered tissues or therapeutic approaches.

  • Developing biomimetic materials inspired by Calsequestrin-1's calcium buffering capabilities for applications in tissue engineering or drug delivery.

• Connecting computational with experimental approaches:

  • Using machine learning to identify patterns in Calsequestrin-1 sequence-structure-function relationships that might not be apparent through traditional analysis.

  • Developing predictive models of how sequence variations affect function, which can then guide targeted experimental studies.

• Integrating ecological physiology with molecular biology:

  • Relating species-specific adaptations in Calsequestrin-1 to ecological niches, environmental challenges, and behavioral repertoires.

  • Investigating how environmental factors might influence Calsequestrin-1 expression and function across different habitats and seasons.

By breaking down traditional disciplinary boundaries, these integrative approaches can generate novel hypotheses, unexpected insights, and innovative applications that would not emerge from any single field alone. Such interdisciplinary work represents the frontier of Calsequestrin-1 research and holds great promise for advancing both basic science understanding and potential biomedical applications.